Presence of serum carbonic anhydrase autoantibodies in patients relapsed after autologous stem cell transplantation indicates an improved prognosis

Neoplasma

Volumn 55, Issue 6, 2008, Pages 488-492

  Lakota, J ^a,c   Skultety, L ^b   Dubrovcakova, M ^c   Altaner, C ^c  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Carbonic anhydrases; Serum autoantibodies; Spontaneous remission; Stem cell transplantation

Indexed keywords

AUTOANTIBODY; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII;

ANTIBODY BLOOD LEVEL; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; IMMUNOREACTIVITY; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PROGNOSIS; AUTOTRANSPLANTATION; BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; RECURRENT DISEASE;

AUTOANTIBODIES; CARBONIC ANHYDRASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MULTIPLE MYELOMA; PROGNOSIS; RECURRENCE; TRANSPLANTATION, AUTOLOGOUS;

EID: 59749092232     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. THOMAS ED, BLUME KG, FORMAN SJ, editors. Hematopoetic Cell Transplantation. Oxford: Blackwell Scientific Publications, 1999.
2. ARMITAGE JO, ANTMUN KH, editors. High-dose Cancer Therapy. Lippincott Williams & Wilkins, 2000.
3. LAKOTA J, VRANOVSKY A, LADICKA M. Spontaneous regression of tumors relapsed following high dose chemotherapy and autologous stem cell transplantation: a relationship with an aplastic anemia type syndrome? Exp Oncol 2003; 25: 285-288.
4. NISSEN C, SCHUBERT J. Seeing the good and bad in aplastic anemia: is autoimmunity in AA dysregulated or anti-neoplastic? Hematol J 2002; 3: 169-175.
5. SATZGER I, MEIER A, SCHENCK F, et al. Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha. Int J Cancer 2007; 121: 2562-2566.
6. NORDLUND JJ, KIRKWOOD JM, FORGET BM, et al. Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 1983; 9: 689-696.
7. RAANANI P, BEN BASSAT I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 2002; 107: 133-144. (Pubitemid 34455077)
8. FRANZKE A, PEEST D, PROBST-KEPPER M, et al. Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer. J Clin Oncol 1999; 17: 529-533.
9. LAKOTA J, FUCHSBERGER P. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Bone Marrow Transplant 1996; 18: 262-263.
10. RABILLOUD T, editor. Proteome Research: Two-Dimensional Gel Electrophoresis and Identification Methods, Springer Verlag, 2000.
11. KUZELA S, LUCIAKOVA K, LAKOTA J. Amino acid incorporation by isolated rat liver mitochondria into two protein components of mitochondrial ATPase complex. Lack of incorporation into dicyclohexylcarbodiimide binding proteolipid. FEBS Lett 1980; 114: 197-201.
12. NISHIMORI I, MIYAJI E, MORIMOTO K, et al. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 2005; 54: 274-281. (Pubitemid 40139246)
13. NISHIMORI I , AKISAWA N, MIYAJI E, et al. Serum antibody to carbonic anhydrase II in patients with chronic viral hepatitis: a review of its prevalence in liver diseases. Hepatology Research 2004; 30: 210-213.
14. TAKEMOTO F, HOSHINO J, SAWA N, et al. Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome. Am J Med 2005; 118: 181-184.
15. BYSTRYN JC, RIGEL D. FRIEDMAN RJ, et al. Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 1987; 123: 1053-1055. (Pubitemid 17134848)
16. HAAPASALO JA, NORDFORS KM, HILVO M, et al. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 2006; 12: 473-477.
17. UNWIN RD, HARNDEN P, PAPPIN D, et al. Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma. Proteomics 2003; 3: 45-55.
18. JONUSYS AM, COX KO, STEELE EJ. IgM natural autoantibodies against bromelain-treated mouse red blood cells recognise carbonic anhydrase. Autoimmunity 1991; 9: 207-216.
19. HAAPASALO J, NORDFORS K, JÄRVELÄ S, et al. Carbonic anhydrase II in the endothelium of glial tumors: A potential target for therapy. Neuro-Oncology 2007; 9: 308-313.
20. PARKKILA S, PARKKILA AK, JUVONEN T, et al. Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours. Histochem J 1995; 27: 133-138.
21. KIVELA AJ, SAARNIO J, KARTTUNEN TJ, et al. Differential expression of cytoplasmic carbonic anhydrases, CA I and II and membrane-associated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors. Dig Dis Sci 2001; 46: 2179-2186.
22. LEPPILAMPI M, KOISTINEN P, SAVOLAINEN ER, et al. The expression of carbonic anhydrase II in hematological malignancies. Clin Cancer Res 2002; 8: 2240-2245. (Pubitemid 34753596)
23. GIATROMANOLAKI A, KOUKOURAKIS MI, SIVRIDIS E, et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001; 61: 7992-7998.
24. SOLTYSOVA A, ALTANEROVA V, ALTANER C. Cancer stem cells. Neoplasma 2005; 52: 435-440.
25. PASTOREKOVA S, ZAVADA J. Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy. Cancer Ther 2004; 2: 245-262.
26. YOSHIURA K, NAKAOKA T, NISHISHITA T, et al. Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res 2005; 11: 8201-8207.
27. PARKKILA S, RAJANIEMI H, PARKKILA AK, et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 2000; 97: 2220-2224.
28. BUI MH, VISAPAA H, SELIGSON D, et al. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. J Urol 2004; 171: 2461-2466. (Pubitemid 38625515)
29. PASTOREKOVA S, PARKKILA S, PASTOREK J, et al. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004; 19: 199-229.